Bersanlimab is an investigational monoclonal antibody directed against intercellular adhesion molecule 1 (ICAM-1).
Bersanlimab is an investigational monoclonal antibody directed against intercellular adhesion molecule 1 (ICAM-1).
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.